C. Tran‐Perennou

发表

Role of chemotherapy resistance genes in outcome of neuroblastoma

P. Fehlbaum, O. Delattre, J. Klijanienko, 2007, Pediatric blood & cancer.

A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

A. Vincent-Salomon, O. Delattre, M. Poupon, 2007, Clinical Cancer Research.

Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays.

B. Asselain, C. Elie, M. Poupon, 2002, Biochemical pharmacology.

Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.

J. Bertherat, X. Bertagna, P. de Cremoux, 2008, Endocrine-related cancer.

Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response

A. Chapelier, M. Poupon, M. Rebucci, 2007, International journal of cancer.

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

Jean-Marc Guinebretière, Nicolas Servant, Bernard Asselain, 2011, BMC Cancer.

Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens.

N. Brünner, P. de Cremoux, A. Lykkesfeldt, 2003, Endocrine-related cancer.

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment

M. Bollet, N. Servant, G. Almouzni, 2009, Breast Cancer Research.

In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy

X. Sastre, M. Poupon, P. de Cremoux, 2005, International journal of cancer.

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

E. Berns, R. Rouzier, I. Bièche, 2021, Clinical Cancer Research.

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

R. Rouzier, I. Bièche, F. Bidard, 2021, ESMO open.

Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.

S. Urien, P. de Cremoux, P. Vielh, 2004, Journal of the National Cancer Institute.

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.

I. Bièche, B. Asselain, V. Bécette, 2004, Endocrine-related cancer.

HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports

A. Vincent-Salomon, R. Rouzier, E. Laas, 2019, BMC Cancer.

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.

J. Limacher, O. Lantz, E. Piaggio, 2023, European journal of cancer.